Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease

Abstract

IntroductionButyrylcholinesterase (BChE) is involved in the metabolism of endogenous lipids and xenobiotics, such as esters of carboxylic or phosphoric acids. Butyrylcholinesterase activity is associated with both inflammation and oxidative stress. Changes in the activity of this enzyme have been observed in various diseases such as liver cirrhosis, diabetes, neurodegenerative disease and others.Material and methodsThe study involved 30 patients with chronic obstructive pulmonary disease (COPD) and 18 healthy subjects. The COPD patients were divided according to the severity of the disease by applying the classification of COPD based on GOLD standards for forced expiratory volume in 1 s (FEV1) and the FEV1/forced expiratory volume (FVC) ratio. The control group comprised blood samples collected from healthy subjects without concomitant diseases related to the respiratory system. Butyrylcholinesterase activity, lipid peroxidation and total antioxidant capacity (TAC) were determined in the blood plasma.ResultsA significant (p < 0.05) decrease in the activity of BChE, associated with an increase in lipid peroxidation and a decrease in the total antioxidant capacity, was observed in blood plasma of patients with chronic obstructive pulmonary disease.ConclusionsThe study shows for the first time that activity of BChE in the blood plasma of patients diagnosed with chronic obstructive pulmonary disease is considerably reduced compared with healthy subjects. These changes were accompanied by a decrease of TAC and an increase of lipid peroxidation, which suggests that they may be related to the oxidative stress induced by COPD disease.

Bergapten Improves Scopolamine-Induced Memory Impairment in Mice via Cholinergic and Antioxidative Mechanisms

“…BChE is another form of cholinesterase and catalyzes the hydrolysis of ACh. When neuronal cells are destroyed, the level of BChE automatically becomes higher ( Bukowska et al, 2017 ).…”

The Gene Expression Biomarkers for Chronic Obstructive Pulmonary Disease and Interstitial Lung Disease

“…DUSP1 (dual specificity phosphatase 1) ranked 16th was reported to have anti-inflammatory potential (Newton, 2014) and when COPD patients undertook fluticasone propionate, DUSP1 expression level was increased (Lee et al, 2016). BCHE (butyrylcholinesterase) ranked 22nd was associated with oxidative stress and inflammation, and its activity was found to be decreased in COPD patients (Sicinska et al, 2017). In Figure 3 , we also observed the downregulation of BCHE in COPD cluster.…”

Lycium barbarum polysaccharides exert an antioxidative effect on rat chondrocytes by activating the nuclear factor (erythroid-derived 2)-like 2 signaling pathway

“…In the present study, cell viability was suppressed in H 2 O 2 -stimulated chondrocytes in a dose-dependent manner (Figure 1 C). Recently, oxidative stress is considered as major cause of OA pathogenesis [26], which is mainly attributed to the imbalance of redox hemostasis between ROS generation and its removal by antioxidant enzymes [33][34][35][36][37]. LBP is reported to facilitate the alleviation of oxidative stress.…”